Skip to main content
Erschienen in: Journal of General Internal Medicine 2/2011

01.02.2011 | Original Research

Patient Navigation to Increase Mammography Screening Among Inner City Women

verfasst von: Christine E. Phillips, MD, Jessica D. Rothstein, BA, Kristine Beaver, MPH, Bonnie J. Sherman, PhD, Karen M. Freund, MD, MPH, Tracy A. Battaglia, MD, MPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Lower mammography screening rates among minority and low income women contribute to increased morbidity and mortality from breast cancer.

Objective

To evaluate the effect of a patient navigation intervention on adherence rates to biennial screening mammography among women engaged in primary care at an inner-city academic medical center.

Design

Quality improvement intervention with a concurrent control group, conducted from February to November of 2008.

Study Subjects

All women in a hospital-based primary care practice aged 51–70 years. Subjects were randomized at the level of their primary care provider, such that half of the patients in the practice received the intervention, while the other half received usual care.

Interventions

Intervention subjects whose last mammogram was >18 months prior received a combination of telephone calls and reminder letters from patient navigators trained to identify barriers to care. Navigators were integrated into primary care teams and interacted directly with patients, providers, and radiology to coordinate care. Navigators utilized an electronic report to track subjects. Adherence rates to biennial mammography were assessed in intervention and control groups at baseline and post-intervention.

Key Results

A total of 3,895 women were randomized to intervention (n = 1,817) and control (n = 2,078) groups. Mean age was 60, 71% were racial/ethnic minorities, 23% were non-English speaking, and 63% had public or no health insurance. At baseline, there was no difference in mammography adherence between the control and intervention groups (78%, respectively, p = 0.55). After the 9-month intervention, mammogram adherence was higher in the intervention group compared with the control group (87% vs. 76%, respectively, p < 0.001). Except among Hispanic women who demonstrated high rates in both the intervention and control groups (85% and 83%, respectively), all racial/ethnic and insurance groups demonstrated higher adherence in the intervention group.

Conclusions

Patient navigation improves biennial mammography rates for inner city, low income, minority populations.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Kagawa-Singer M, Dadia AV, Yu MC, Surbone A. Cancer, culture, and health disparities: time to chart a new course? CA Cancer J Clin. 2010;60(1):12–39.CrossRefPubMed Kagawa-Singer M, Dadia AV, Yu MC, Surbone A. Cancer, culture, and health disparities: time to chart a new course? CA Cancer J Clin. 2010;60(1):12–39.CrossRefPubMed
4.
Zurück zum Zitat Hershman D, McBride R, Jacobson JS, et al. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol. 2005;23(27):6639–46.CrossRefPubMed Hershman D, McBride R, Jacobson JS, et al. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol. 2005;23(27):6639–46.CrossRefPubMed
5.
Zurück zum Zitat Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987–2005). Cancer Epidemiol Biomark Prev. 2009;18(1):121–31.CrossRef Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987–2005). Cancer Epidemiol Biomark Prev. 2009;18(1):121–31.CrossRef
6.
Zurück zum Zitat Smith-Bindman R, Miglioretti DL, Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006;144(8):541–53.PubMed Smith-Bindman R, Miglioretti DL, Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006;144(8):541–53.PubMed
8.
Zurück zum Zitat Legler J, Meissner HI, Coyne C, Breen N, Chollette V, Rimer BK. The effectiveness of interventions to promote mammography among women with historically lower rates of screening. Cancer Epidemiol Biomark Prev. 2002;11(1):59–71. Legler J, Meissner HI, Coyne C, Breen N, Chollette V, Rimer BK. The effectiveness of interventions to promote mammography among women with historically lower rates of screening. Cancer Epidemiol Biomark Prev. 2002;11(1):59–71.
9.
Zurück zum Zitat Wells KJ, Battaglia TA, Dudley DJ, et al. Patient navigation: state of the art or is it science? Cancer. 2008;113(8):1999–2010.CrossRefPubMed Wells KJ, Battaglia TA, Dudley DJ, et al. Patient navigation: state of the art or is it science? Cancer. 2008;113(8):1999–2010.CrossRefPubMed
10.
Zurück zum Zitat Battaglia TA, Roloff K, Posner MA, Freund KM. Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention. Cancer. 2007;109(2 Suppl):359–67.CrossRefPubMed Battaglia TA, Roloff K, Posner MA, Freund KM. Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention. Cancer. 2007;109(2 Suppl):359–67.CrossRefPubMed
11.
Zurück zum Zitat Ell K, Vourlekis B, Lee PJ, Xie B. Patient navigation and case management following an abnormal mammogram: a randomized clinical trial. Prev Med. 2007;44(1):26–33.CrossRefPubMed Ell K, Vourlekis B, Lee PJ, Xie B. Patient navigation and case management following an abnormal mammogram: a randomized clinical trial. Prev Med. 2007;44(1):26–33.CrossRefPubMed
12.
Zurück zum Zitat Psooy BJ, Schreuer D, Borgaonkar J, Caines JS. Patient navigation: improving timeliness in the diagnosis of breast abnormalities. Can Assoc Radiol J. 2004;55(3):145–50.PubMed Psooy BJ, Schreuer D, Borgaonkar J, Caines JS. Patient navigation: improving timeliness in the diagnosis of breast abnormalities. Can Assoc Radiol J. 2004;55(3):145–50.PubMed
13.
Zurück zum Zitat Ferrante JM, Chen PH, Kim S. The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health. 2008;85(1):114–24.CrossRefPubMed Ferrante JM, Chen PH, Kim S. The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health. 2008;85(1):114–24.CrossRefPubMed
14.
Zurück zum Zitat Lobb R, Allen JD, Emmons KM, Ayanian JZ. Timely care after an abnormal mammogram among low-income women in a public breast cancer screening program. Arch Intern Med. 2010;170(6):521–8.CrossRefPubMed Lobb R, Allen JD, Emmons KM, Ayanian JZ. Timely care after an abnormal mammogram among low-income women in a public breast cancer screening program. Arch Intern Med. 2010;170(6):521–8.CrossRefPubMed
15.
Zurück zum Zitat Dignan MB, Burhansstipanov L, Hariton J, et al. A comparison of two Native American Navigator formats: face-to-face and telephone. Cancer Control. 2005;12(Suppl 2):28–33.PubMed Dignan MB, Burhansstipanov L, Hariton J, et al. A comparison of two Native American Navigator formats: face-to-face and telephone. Cancer Control. 2005;12(Suppl 2):28–33.PubMed
16.
Zurück zum Zitat Paskett E, Tatum C, Rushing J, et al. Randomized trial of an intervention to improve mammography utilization among a triracial rural population of women. J Natl Cancer Inst. 2006;98(17):1226–37.CrossRefPubMed Paskett E, Tatum C, Rushing J, et al. Randomized trial of an intervention to improve mammography utilization among a triracial rural population of women. J Natl Cancer Inst. 2006;98(17):1226–37.CrossRefPubMed
17.
Zurück zum Zitat Han HR, Lee H, Kim MT, Kim KB. Tailored lay health worker intervention improves breast cancer screening outcomes in non-adherent Korean-American women. Health Educ Res. 2009;24(2):318–29.CrossRefPubMed Han HR, Lee H, Kim MT, Kim KB. Tailored lay health worker intervention improves breast cancer screening outcomes in non-adherent Korean-American women. Health Educ Res. 2009;24(2):318–29.CrossRefPubMed
18.
Zurück zum Zitat HEDIS. Technical Specifications, Vol. 2. Washington, D.C: National Committee for Quality Assurance; 2007. HEDIS. Technical Specifications, Vol. 2. Washington, D.C: National Committee for Quality Assurance; 2007.
19.
21.
Zurück zum Zitat Ward MD, Rieve JA. The role of case management in disease management. In: Todd WE, Nash E, eds. Disease management: A Systems Approach to Improving Patient Outcomes. Chicago, IL: American Hospital Publishing; 1997:235–59. Ward MD, Rieve JA. The role of case management in disease management. In: Todd WE, Nash E, eds. Disease management: A Systems Approach to Improving Patient Outcomes. Chicago, IL: American Hospital Publishing; 1997:235–59.
22.
Zurück zum Zitat Laiteerapong N, Sherman BJ, Kim K, Freund K. Validation of racial categorization in a hospital administrative database. J Gen Intern Med. 2005;20(Suppl 1):130. Laiteerapong N, Sherman BJ, Kim K, Freund K. Validation of racial categorization in a hospital administrative database. J Gen Intern Med. 2005;20(Suppl 1):130.
24.
Zurück zum Zitat Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program Fact Sheet 2004/2005. Atlanta, GA: Centers for Disease Control and Prevention; 2005. Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program Fact Sheet 2004/2005. Atlanta, GA: Centers for Disease Control and Prevention; 2005.
25.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed
26.
Zurück zum Zitat Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9.CrossRefPubMed Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9.CrossRefPubMed
27.
Zurück zum Zitat Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60(2):99–119.CrossRefPubMed Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60(2):99–119.CrossRefPubMed
28.
Zurück zum Zitat David MM, Ko L, Prudent N, Green EH, Posner MA, Freund KM. Mammography use. J Natl Med Assoc. 2005;97(2):253–61.PubMed David MM, Ko L, Prudent N, Green EH, Posner MA, Freund KM. Mammography use. J Natl Med Assoc. 2005;97(2):253–61.PubMed
29.
Zurück zum Zitat Palmer RC, Fernandez ME, Tortolero-Luna G, Gonzales A, Mullen DP. Acculturation and mammography screening among Hispanic women living in farmworker communities. Cancer Control. 2005;12(Suppl 2):21–7.PubMed Palmer RC, Fernandez ME, Tortolero-Luna G, Gonzales A, Mullen DP. Acculturation and mammography screening among Hispanic women living in farmworker communities. Cancer Control. 2005;12(Suppl 2):21–7.PubMed
30.
Zurück zum Zitat Zambrana RE, Breen N, Fox SA, Gutierrez-Mohamed ML. Use of cancer screening practices by Hispanic women: analyses by subgroup. Prev Med. 1999;29(6 Pt 1):466–77.CrossRefPubMed Zambrana RE, Breen N, Fox SA, Gutierrez-Mohamed ML. Use of cancer screening practices by Hispanic women: analyses by subgroup. Prev Med. 1999;29(6 Pt 1):466–77.CrossRefPubMed
32.
Zurück zum Zitat Fisher ES. Building a medical neighborhood for the medical home. N Engl J Med. 2008;359(12):1202–5.CrossRefPubMed Fisher ES. Building a medical neighborhood for the medical home. N Engl J Med. 2008;359(12):1202–5.CrossRefPubMed
35.
Zurück zum Zitat Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716–26 Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716–26
36.
Zurück zum Zitat Qaseem A, Snow V, Sherif K, Aronson M, Weiss KB, Owens DK. Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007;146(7):511–5.PubMed Qaseem A, Snow V, Sherif K, Aronson M, Weiss KB, Owens DK. Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007;146(7):511–5.PubMed
38.
Zurück zum Zitat Steinbrook R. Health Care and the American Recovery and Reinvestment Act. N Engl J Med. 2009;360(11):1057–1060.CrossRefPubMed Steinbrook R. Health Care and the American Recovery and Reinvestment Act. N Engl J Med. 2009;360(11):1057–1060.CrossRefPubMed
Metadaten
Titel
Patient Navigation to Increase Mammography Screening Among Inner City Women
verfasst von
Christine E. Phillips, MD
Jessica D. Rothstein, BA
Kristine Beaver, MPH
Bonnie J. Sherman, PhD
Karen M. Freund, MD, MPH
Tracy A. Battaglia, MD, MPH
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 2/2011
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-010-1527-2

Weitere Artikel der Ausgabe 2/2011

Journal of General Internal Medicine 2/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.